Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: United States Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20037
20046
20057
20064
20078
20088
20096
201010
20118
20128
20133
20143
20151
20163
20172
20184
20194
20213
20221
20234
20246
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Terminated17
Recruiting13
Active, not recruiting9
Unknown status7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Takeda10
AstraZeneca7
Eli Lilly and Company7
National Heart, Lung, and Blood Institute (NHLBI)7
GlaxoSmithKline5
Hoffmann-La Roche4
University of California, San Francisco4
Amgen3
Brigham and Women's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases131
Heart Diseases27
Hypertension24
Myocardial Infarction22
Atherosclerosis15
Diabetes Mellitus, Type 214
Heart Failure14
Stroke14
Vascular Diseases14
Dyslipidemias12

Trials

Showing 1 to 25 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.